Source: https://www.nature.com/articles/35025229?error=cookies_not_supported&code=7a63821e-33c3-4caf-98eb-7e7ccfd38847
Timestamp: 2019-04-21 23:03:34+00:00

Document:
How does the coagulation protease thrombin regulate cellular behaviour? The protease-activated receptors (PARs) provide one answer. In concert with the coagulation cascade, these receptors provide an elegant mechanism linking mechanical information in the form of tissue injury or vascular leakage to cellular responses. Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development.
Colman, R. W., Marder, V. J., Salzman, E. W. & Hirsh, J. in Hemostasis and Thrombosis (eds Colman, R. W., Marder, V. J., Salzman, E. W. & Hirsh, J.) 3–18 (Lippincott, Philadelphia, 1994).
Esmon, C. T. et al. Inflammation, sepsis, and coagulation. Haematologica 84, 254–259 ( 1999).
Osterud, B. Tissue factor expression by monocytes: regulation and pathophysiological roles . Blood Coag. Fibrin. 9(Suppl. 1), S9–S14 (1998).
Giesen, P. L. et al. Blood-borne tissue factor: another view of thrombosis. Proc. Natl Acad. Sci. USA 96, 2311– 2315 (1999).
Bevilacqua, M. P. & Gimbrone, M. A. Jr Inducible endothelial functions in inflammation and coagulation. Semin. Thromb. Hemost. 13, 425–433 (1987).
Coughlin, S. R. Sol Sherry lecture in thrombosis: how thrombin ‘talks’ to cells: molecular mechanisms and roles in vivo. Arterioscl. Thromb. Vasc. Biol. 18, 514–518 (1998).
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V. & Bainton, D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101, 880–886 (1985).
Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591– 594 (1998).
Hughes, P. E. & Pfaff, M. Integrin affinity modulation. Trends Cell Biol. 8, 359–364 (1998).
Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J. & Shattil, S. J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J. Biol. Chem. 264, 17049–17057 (1989).
Hattori, R., Hamilton, K. K., Fugate, R. D., McEver, R. P. & Sims, P. J. Stimulated secretion of endothelial vWF is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J. Biol. Chem. 264 , 7768–7771 (1989).
Subramaniam, M. et al. Defects in hemostasis in P-selectin-deficient mice. Blood 87, 1238–1242 ( 1996).
Frenette, P. S., Mayadas, T. N., Rayburn, H., Hynes, R. O. & Wagner, D. D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84, 563–574 ( 1996).
Lum, H. & Malik, A. B. Regulation of vascular endothelial barrier function. Am. J. Physiol. 267, L223 –L241 (1994).
Cirino, G. et al. Thrombin functions as an inflammatory mediator through activation of its receptor. J. Exp. Med. 183, 821– 827 (1996).
Coughlin, S. R. How the protease thrombin talks to cells. Proc. Natl Acad. Sci. USA 96, 11023–11027 ( 1999).
Vu, T.-K. H., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057–1068 (1991).
Rasmussen, U. B. et al. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett. 288, 123–128 (1991).
Chen, J., Ishii, M., Wang, L., Ishii, K. & Coughlin, S. R. Thrombin receptor activation: confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem. 269, 16041–16045 (1994).
O'Brien, P. J. et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13502– 13509 (2000).
Ishii, K., Hein, L., Kobilka, B. & Coughlin, S. R. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268, 9780–9786 (1993).
Bernatowicz, M. S. et al. Development of potent thrombin receptor antagonist peptides . J. Med. Chem. 39, 4879– 4887 (1996).
Ishihara, H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502– 506 (1997).
Xu, W. F. et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642– 6646 (1998).
Kahn, M. L. et al. A dual thrombin receptor system for platelet activation. Nature 394, 690–694 ( 1998).
Nystedt, S., Emilsson, K., Wahlestedt, C. & Sundelin, J. Molecular cloning of a potential novel proteinase activated receptor. Proc. Natl Acad. Sci. USA 91, 9208– 9212 (1994).
Molino, M. et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272, 4043– 4049 (1997).
Camerer, E., Huang, W. & Coughlin, S. R. Tissue factor- and Factor X-dependent activation of PAR2 by Factor VIIa. Proc. Natl Acad. Sci. USA 97 , 5255–5260 (2000).
Nakanishi-Matsui, M. et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609–613 ( 2000).
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. & Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879–887 ( 1999).
Hung, D. T., Vu, T. K., Wheaton, V. I., Ishii, K. & Coughlin, S. R. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J. Clin. Invest. 89, 1350–1353 ( 1992).
Brass, L. F. et al. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J. Biol. Chem. 267, 13795–13798 (1992).
Selak, M. A., Chignard, M. & Smith, J. B. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem. J. 251, 293– 299 (1988).
Sambrano, G. R. et al. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275, 6819– 6823 (2000).
Shapiro, M. J., Weiss, E. J., Faruqi, T. R. & Coughlin, S. R. Protease-activated receptors 1 and 4 are shutoff with distinct tempos after activation by thrombin. J. Biol. Chem. (in the press).
Okamura, T., Hasitz, M. & Jamieson, G. A. Platelet glycocalicin: interaction with thrombin and role as thrombin receptor on the platelet surface. J. Biol. Chem. 253, 3435–3443 ( 1978).
Andrews, R. K. et al. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb. Haemost. 82, 357– 364 (1999).
Connolly, T. M. et al. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb. Haemost. 72, 627–633 (1994).
Derian, C. K., Santulli, R. J., Tomko, K. A., Haertlein, B. J. & Andrade-Gordon, P. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation and regulation by protein kinases. Thromb. Res. 6, 505–519 (1995).
Connolly, A. J., Ishihara, H., Kahn, M. L., Farese, R. V. & Coughlin, S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381, 516–519 (1996).
Zimmerman, G. A. et al. Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. Adv. Exp. Med. Biol. 416 , 297–304 (1996).
Johnson, K. et al. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J. Immunol. 160 , 5130–5135 (1998).
Cunningham, M. A. et al. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J. Exp. Med. 191, 455–462 (2000).
Bugge, T. H., et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc. Natl Acad. Sci. USA 93, 6258–6263 (1996).
Hung, D. T., Wong, Y. H., Vu, T.-K. H. & Coughlin, S. R. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate both phosphoinositide hydrolysis and inhibit adenylyl cyclase . J. Biol. Chem. 353, 20831– 20834 (1992).
Offermanns, S., Laugwitz, K.-L., Spicher, K. & Schultz, G. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc. Natl Acad. Sci. USA 91, 504–508 (1994).
Barr, A. J., Brass, L. F. & Manning, D. R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor–G protein coupling. J. Biol. Chem. 272 , 2223–2229 (1997).
Kozasa, T. et al. p115 RhoGEF, a GTPase-activating protein for Galpha12 and Galpha13. Science 280, 2109– 2111 (1998).
Hart, M. J. et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Gα13 Science 280 , 2112–2114 (1998).
Fukuhara, S., Murga, C., Zohar, M., Igishi, T. & Gutkind, J. S. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J. Biol. Chem. 274, 5868–5879 ( 1999).
Klages, B., Brandt, U., Simon, M. I., Schultz, G. & Offermanns, S. Activation of G12/G13 results in shape change and rho/rho kinase-mediated myosin light chain phosphorylation in mouse platelets. J. Cell. Biol. 144, 745–754 (1999).
Vouret-Craviari, V., Boquet, P., Pouysségur, J. & Van Obberghen-Schilling, E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol. Biol. Cell 9, 2639–2653 (1998).
Offermanns, S., Mancino, V., Revel, J.-P. & Simon, M. I. Vascular system defects and impaired cell chemokinesis as a result of Gα 13 deficiency. Science 275, 533– 536 (1997).
Taylor, S., Chae, H. Z., Rhee, S.-G. & Exton, J. H. Activation of the B1 isozyme of phospholipase C by a subunits of the Gq class of G proteins . Nature 350, 516–518 (1991).
Offermanns, S., Toombs, C. F., Hu, Y. H. & Simon, M. I. Defective platelet activation in Gαq-deficient mice. Nature 389, 183–186 (1997).
Stoyanov, B. et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690–693 (1995).
Clapham, D. E. & Neer, E. J. G protein beta gamma subunits. Annu. Rev. Pharmacol. Toxicol. 37, 167–203 (1997).
Leevers, S. J., Vanhaesebroeck, B. & Waterfield, M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11 , 219–225 (1999).
Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884–888 (1999).
Esmon, C. T. Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 95, 1113– 1116 (2000).
Esmon, C. T. et al. Regulation and functions of the protein C anticoagulant pathway . Haematologica 84, 363– 368 (1999).
Palabrica, T. et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848–851 (1992).
Nystedt, S., Ramakrishnan, V. & Sundelin, J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor . J. Biol. Chem. 271, 14910– 14915 (1996).
Inbal, A. et al. Purpura fulminans induced by disseminated intravascular coagulation following infection in 2 unrelated children with double heterozygosity for factor V Leiden and protein S deficiency. Thromb. Haemost. 77, 1086–1089 (1997).
I thank B. Black, H. Bourne, I. Charo, P.-T. Chuang, C. Esmon and the members of my laboratory for critical reading of the manuscript, and T. Schoop for illustrations.
Correspondence to Shaun R. Coughlin.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.